The event addressed the most relevant issues in the field of assisted reproduction, including:
- Hormone therapy and the risks of thrombotic complications;
- Ovarian stimulation and the associated risks and prevention of thromboembolic events (VTE);
- Legal intricacies of the new clinical guidelines for female infertility;
- Modern possibilities for assessing the endometrial microbiota and its impact on ART outcomes;
- The effectiveness of sperm selection for ICSI using microfluidics;
- The use of FSH therapy in idiopathic male infertility: pros and cons;
- The importance of medical-genetic counseling at the pre-gravid stage, with examples of clinical cases;
- Fertility preservation in patients with malignant ovarian tumors;
- ART outcomes in patients with rare genetic anomalies and many others.


